It's a little pill with big responsibilities. But despite its primary role to prevent pregnancy, the contraceptive pill (the Pill) could also help reduce the risk of ovarian cancer, according to research from the University ...
Feb 3, 2025
0
1
A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced and health care savings boosted if women who have already completed their families were offered fallopian tube removal ...
Jan 30, 2025
0
31
Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently more than 300,000 new cases and 200,000 deaths annually, according to data from the World Health ...
Ovarian cancer has seen a significant shift in its treatment paradigm with the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, which are now standard in the maintenance setting following first-line chemotherapy.
Jan 23, 2025
0
1
Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most prevalent and deadliest forms of ovarian cancer. Their work is published in the journal npj Genomic ...
Jan 23, 2025
0
17
A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is published in Nature ...
Jan 2, 2025
0
22
Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right patients at the right time, ...
Dec 10, 2024
0
63
An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Dec 6, 2024
0
0
Researchers have developed a three-step plan to support those burdened by the intense fear of cancer recurrence. This plan offers a consistent, streamlined approach to managing recurrence anxiety, empowering patients to regain ...
Dec 2, 2024
0
0
The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and colleagues have discovered a new approach to treating ovarian cancer, ...
Nov 21, 2024
0
0
